Children
Early Cardiotoxicity in Pediatric Patients with Acute Lymphoblastic Leukemia and Hodgkin Lymphoma: Incidence, Risk Factors, and Clinical Implications
By Ronja Meyer, Leonie Dewein, Tobias Baumann and 4 others.
Abstract
Background
Cardiotoxicity is a major adverse effect of antineoplastic therapy in pediatric oncology, potentially leading to long-term morbidity. This study aimed to evaluate the incidence, spectrum, and risk factors of early cardiovascular (CV) complications in children treated for acute lymphoblastic leukemia (ALL) and Hodgkin lymphoma (HL).
